688139
vs
S
Shanghai Composite
688139
Over the past 12 months, Qingdao Haier Biomedical Co Ltd has underperformed Shanghai Composite, delivering a return of -2% compared to the Shanghai Composite's +22% growth.
Stocks Performance
688139 vs Shanghai Composite
Performance Gap
688139 vs Shanghai Composite
Performance By Year
688139 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Qingdao Haier Biomedical Co Ltd
Glance View
Qingdao Haier Biomedical Co Ltd, nestled within the vibrant hub of Qingdao, China, has been a dynamic player in the life sciences and healthcare industry since its inception. Originally part of the expansive Haier Group, known globally for its household appliances, Haier Biomedical has carved out a niche by focusing intently on the intersection of cold chain logistics and biomedical engineering. Its product line is built around the essential needs of the healthcare, pharmaceutical, and research sectors, where precise temperature control is not just an operational nicety but a critical necessity. The company's range of equipment—from ultra-low temperature freezers to blood bank refrigerators and smart cold storage solutions—acts as the backbone for preserving biological samples, vaccines, and medications. By pioneering smart technology integration within these systems, the company effectively meets stringent global standards, ensuring the safety and efficacy of conserved biological materials. The commercial success of Haier Biomedical stems from its dual strategy of deeply engaging with international markets while continuously innovating its product offerings. The company makes money by selling its high-tech storage and transport solutions to a vast array of clients including hospitals, research laboratories, and pharmaceutical manufacturers around the globe. This revenue model is bolstered by its ability to tap into an ever-growing demand for efficient biological storage, driven by global health initiatives and the rising importance of biotech advancements. Meanwhile, its continuous investment in R&D has positioned it as a leader in smart cold chain logistics, enabling it to adapt swiftly to the rapidly evolving landscape of global healthcare needs. By leveraging its technical expertise and maintaining strong relationships with sector stakeholders across the world, Haier Biomedical consistently achieves a robust financial performance, underpinned by its commitment to quality and innovation in the biomedical field.
